NLB 2016: Case #2, 3 Bone Health, Renal Health, 1+Prior Therapies, Immunotherapy, Clonal Evolution
Previous Post
NLB 2016 Case 4,5,6 Relapsed Myeloma, Treatment for Relapsed MM, Drugs in Development
Next Post
NLB 2016: Case Study #1 Newly Diagnosed MM, Diagnostic Criteria, Response, MRD




